Related Experiment Video
Updated: Jan 31, 2026

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
Sara Maimouni1, Naiem Issa2, Selina Cheng2
1Department of Biochemical, Molecular and Cellular Biology, Georgetown University, Washington, District of Columbia, United States of America.
Abstract:
Retinoic acid receptor responder 1 (RARRES1) is silenced in many cancers and is differentially expressed in metabolism associated diseases, such as hepatic steatosis, hyperinsulinemia and obesity. Here we report a novel function of RARRES1 in metabolic reprogramming of epithelial cells. Using non-targeted LC-MS, we discovered that RARRES1 depletion in epithelial cells caused a global increase in lipid synthesis. RARRES1-depleted cells rewire glucose metabolism by switching from aerobic glycolysis to glucose-dependent de novo lipogenesis (DNL). Treatment with fatty acid synthase (FASN) inhibitor, C75, reversed the effects of RARRES1 depletion. The increased DNL in RARRES1-depleted normal breast and prostate epithelial cells proved advantageous to the cells during starvation, as the increase in fatty acid availability lead to more oxidized fatty acids (FAO), which were used for mitochondrial respiration. Expression of RARRES1 in several common solid tumors is also contextually correlated with expression of fatty acid metabolism genes and fatty acid-regulated transcription factors. Pathway enrichment analysis led us to determine that RARRES1 is regulated by peroxisome proliferating activated receptor (PPAR) signaling. These findings open up a new avenue for metabolic reprogramming and identify RARRES1 as a potential target for cancers and other diseases with impaired fatty acid metabolism.
Insights
Retinoic acid receptor responder 1 (RARRES1) plays a key role in epithelial cell metabolism. Its depletion boosts lipid synthesis and alters glucose metabolism, impacting cell survival during starvation.
Area of Science:
- Cellular metabolism
- Molecular biology
- Oncology
Background:
- Retinoic acid receptor responder 1 (RARRES1) is implicated in cancer and metabolic disorders like hepatic steatosis, hyperinsulinemia, and obesity.
- RARRES1 silencing is observed in numerous cancers.
- Its precise role in metabolic reprogramming remains largely unexplored.
Purpose of the Study:
- To elucidate the novel function of RARRES1 in the metabolic reprogramming of epithelial cells.
- To investigate the impact of RARRES1 depletion on cellular metabolism, particularly lipid and glucose pathways.
- To explore the therapeutic potential of targeting RARRES1 in metabolic diseases and cancer.
Main Methods:
- Non-targeted Liquid Chromatography-Mass Spectrometry (LC-MS) to analyze metabolic changes.
- Gene depletion studies using RARRES1 knockdown in epithelial cells.
- Treatment with fatty acid synthase (FASN) inhibitor C75.
- Analysis of fatty acid oxidation (FAO) and mitochondrial respiration.
- Correlation analysis of RARRES1 expression with metabolic genes in tumors.
- Pathway enrichment analysis focusing on peroxisome proliferating activated receptor (PPAR) signaling.
Main Results:
- RARRES1 depletion globally increased lipid synthesis in epithelial cells.
- Cells lacking RARRES1 shifted glucose metabolism from aerobic glycolysis to de novo lipogenesis (DNL).
- FASN inhibition with C75 reversed the metabolic effects of RARRES1 depletion.
- Increased DNL in RARRES1-depleted cells enhanced fatty acid availability, supporting mitochondrial respiration during starvation.
- RARRES1 expression correlates with fatty acid metabolism genes and transcription factors in solid tumors.
- RARRES1 is regulated by PPAR signaling.
Conclusions:
- RARRES1 plays a critical role in regulating epithelial cell metabolism, particularly lipid synthesis and glucose utilization.
- RARRES1-mediated metabolic reprogramming influences cell adaptation to nutrient deprivation.
- RARRES1 is a potential therapeutic target for cancers and metabolic diseases characterized by impaired fatty acid metabolism.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Regulation of Metabolism
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
What is Metabolism?

